These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 6154207
21. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs. Saini RK, Fulmor IE, Parham CS, Antonaccio MJ. J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960 [Abstract] [Full Text] [Related]
23. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion. Toda I, Nozaki A, Kawakubo K, Murakawa Y, Inoue H, Yoshimoto N, Sugimoto T. Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849 [Abstract] [Full Text] [Related]
24. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine. Komori S, Sawanobori T, Tamura K, Kane KA, Parratt JR. Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519 [Abstract] [Full Text] [Related]
25. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs. Végh A, Parratt JR. Br J Pharmacol; 2002 Dec; 137(7):1107-15. PubMed ID: 12429584 [Abstract] [Full Text] [Related]
27. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs. Imamoto T, Terashita Z, Tanabe M, Nishikawa K, Hirata M. J Cardiovasc Pharmacol; 1986 Dec; 8(4):832-9. PubMed ID: 2427826 [Abstract] [Full Text] [Related]
29. Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart. Pelleg A, Roth A, Shargordsky B, Belhassen B, Chagnac A, Laniado S. Methods Find Exp Clin Pharmacol; 1985 May; 7(5):239-43. PubMed ID: 4033300 [Abstract] [Full Text] [Related]
30. Antiarrhythmic and antifibrillatory action of diltiazem on early and late phase ventricular arrhythmias following coronary artery occlusion and on reperfusion ventricular arrhythmias. Thale J, Gülker H, Olbing B, Rose D, Bender F. Pharmacology; 1986 May; 33(1):1-13. PubMed ID: 3737671 [Abstract] [Full Text] [Related]
32. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. McHugh NA, Cook SM, Schairer JL, Bidgoli MM, Merrill GF. Am J Physiol; 1995 Jun; 268(6 Pt 2):H2569-73. PubMed ID: 7611507 [Abstract] [Full Text] [Related]
33. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo. Sun W, Wainwright CL. Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414 [Abstract] [Full Text] [Related]